lignans and roseoside

lignans has been researched along with roseoside* in 2 studies

Other Studies

2 other study(ies) available for lignans and roseoside

Article	Year
Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells. Molecules (Basel, Switzerland), 2019, Jan-23, Volume: 24, Issue:3 Hypertension is a major risk factor for the development of cardiovascular diseases. This study aimed to elucidate whether the natural product mixture No-ap (NA) containing Topics: Angiotensin II; Animals; Biological Products; Chemokine CCL2; Gene Expression Regulation; Glucosides; Glycosides; Humans; Hydrogen Peroxide; Lignans; Norisoprenoids; Oxidation-Reduction; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2019
Officinalioside, a new lignan glucoside from Borago officinalis L. Natural product research, 2016, Volume: 30, Issue:8 A new lignan glucoside, officinalioside (1), was isolated from n-BuOH fraction of the aerial parts of Borago officinalis L., together with four known compounds: actinidioionoside (2), roseoside (3), crotalionoside C (4) and kaempferol 3-O-β-D-galactopyranoside (5). The structure of the new compound was established by means of spectroscopic and chemical analyses. Compounds 1 and 2 showed a moderate DPPH radical scavenging activity (IC50: 52.6 ± 1.70 and 41.3 ± 0.25 μM, respectively) comparable with that of the standard trolox (16.6 ± 2.2 μM) without any significant cytotoxicity towards human cell line A549 (IC50 > 100 μM). Topics: Borago; Cell Line, Tumor; Free Radical Scavengers; Glucosides; Humans; Kaempferols; Lignans; Molecular Structure; Norisoprenoids; Plant Extracts	2016

Article

Year

Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells.

Molecules (Basel, Switzerland), 2019, Jan-23, Volume: 24, Issue:3

Hypertension is a major risk factor for the development of cardiovascular diseases. This study aimed to elucidate whether the natural product mixture No-ap (NA) containing

Topics: Angiotensin II; Animals; Biological Products; Chemokine CCL2; Gene Expression Regulation; Glucosides; Glycosides; Humans; Hydrogen Peroxide; Lignans; Norisoprenoids; Oxidation-Reduction; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2019

Officinalioside, a new lignan glucoside from Borago officinalis L.

Natural product research, 2016, Volume: 30, Issue:8

A new lignan glucoside, officinalioside (1), was isolated from n-BuOH fraction of the aerial parts of Borago officinalis L., together with four known compounds: actinidioionoside (2), roseoside (3), crotalionoside C (4) and kaempferol 3-O-β-D-galactopyranoside (5). The structure of the new compound was established by means of spectroscopic and chemical analyses. Compounds 1 and 2 showed a moderate DPPH radical scavenging activity (IC50: 52.6 ± 1.70 and 41.3 ± 0.25 μM, respectively) comparable with that of the standard trolox (16.6 ± 2.2 μM) without any significant cytotoxicity towards human cell line A549 (IC50 > 100 μM).

Topics: Borago; Cell Line, Tumor; Free Radical Scavengers; Glucosides; Humans; Kaempferols; Lignans; Molecular Structure; Norisoprenoids; Plant Extracts

2016